Shu Wang
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
-
- Breast Cancer Treatment Studies
Papers in
- Surgery 21
- Breast Implant and Reconstruction 4
- Bladder and Urothelial Cancer Treatments 3
-
- Kidney Stones and Urolithiasis Treatments 4
- Prostate Cancer Diagnosis and Treatment 4
- Co-authors
- Yitian Zhang (3 shared papers)Jianxing Li (2 shared papers)Mohummad Minhaj Siddiqui (7 shared papers)Yuzhe Tang (2 shared papers)Jimmy P.S. Chern (1 shared paper)Dong‐Tsamn Lin (1 shared paper)Shiann‐Tarng Jou (1 shared paper)Kai‐Hsin Lin (1 shared paper)
- Journals
- Journal of Crohn s and Colitis (7 papers)Aesthetic Plastic Surgery (5 papers)World Journal of Urology (2 papers)Cardiovascular Drugs and Therapy (1 paper)Life Sciences (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Shu Wang
71 papers receiving 856 citations
Peers
Comparison fields: 5 of 113
- Otorhinolaryngology 44
- Cancer Research 95
- Pulmonary and Respiratory Medicine 188
- Oncology 154
- Nutrition and Dietetics 72
Countries citing papers authored by Shu Wang
This map shows the geographic impact of Shu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Wang more than expected).
Fields of papers citing papers by Shu Wang
This network shows the impact of papers produced by Shu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Wang. The network helps show where Shu Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Shu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 79 | |
| 2 | 2010 | 72 | |
| 3 | 2003 | 61 | |
| 4 | 2019 | 52 | |
| 5 | 2012 | 42 | |
| 6 | 2020 | 42 | |
| 7 | 2020 | 40 | |
| 8 | 2015 | 34 | |
| 9 | Response to neoadjuvant therapy and disease free survival in patients with triple-negative breast cancer. | 2009 | 31 |
| 10 | 2019 | 26 | |
| 11 | 2023 | 23 | |
| 12 | 2021 | 21 | |
| 13 | 2011 | 21 | |
| 14 | 2020 | 20 | |
| 15 | 2019 | 18 | |
| 16 | 2023 | 17 | |
| 17 | 2019 | 16 | |
| 18 | 2010 | 16 | |
| 19 | 2010 | 16 | |
| 20 | 2005 | 15 |
About Shu Wang
Shu Wang is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Epidemiology, Genetics and Oncology, having authored 81 papers that have together received 879 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (7 papers), Microscopic Colitis (5 papers), Biosimilars and Bioanalytical Methods (4 papers), Kidney Stones and Urolithiasis Treatments (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Breast Implant and Reconstruction (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). The work is most often cited by research in Otorhinolaryngology (44 citations), Cancer Research (95 citations), Pulmonary and Respiratory Medicine (188 citations), Oncology (154 citations) and Nutrition and Dietetics (72 citations). Shu Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yitian Zhang, Jianxing Li, Mohummad Minhaj Siddiqui, Yuzhe Tang, Jimmy P.S. Chern, Dong‐Tsamn Lin, Shiann‐Tarng Jou, Kai‐Hsin Lin, Meng‐Yao Lu and Kuo‐Sin Lin. Their work appears in journals such as Journal of Crohn s and Colitis, Aesthetic Plastic Surgery, World Journal of Urology, Cardiovascular Drugs and Therapy and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.